Allografting for chronic myeloid leukaemia

Bailliere's Clinical Haematology

Volumn 10, Issue 2, 1997, Pages 319-336

  Clift, R A ^a   Anasetti, C ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Chronic myeloid leukaemia; Marrow transplantation; Unrelated donor

Indexed keywords

BUSULFAN;

AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DONOR; GENETICS; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA SYSTEM; HUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REGISTER; REVIEW; SEX DIFFERENCE;

EID: 0030799255     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(97)80010-8     Document Type: Article

References (66)

1. chap. 51 Anasetti C Hansen JA Bone marrow transplantation from HLA-partially matched related donors and unrelated volunteer donors Forman SJ Blume KG Thomas ED Bone Marrow Transplanation 1994 Blackwell Scientific Boston, MA 665 680
2. Anasetti C Amos D Beatty PG Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma New England Journal of Medicine 320 1989 197 204
3. Anasetti C Beatty PG Storb R Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma Human Immunology 29 1990 79 91
4. Arcese W Goldman JM D'Arcangelo E Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia Blood 82 1993 3211 3219
5. Aschan J Ringold GM Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus host disease Clinical Transplantation 8 1994 258 270
6. Atkinson K Farrell C Chapman G Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum British Journal of Haematology 63 1986 231 239
7. Banaji M Bearman SI Buckner CD The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation American Journal of Hematology 22 1986 275 283
8. Beatty PG Clift RA Mickelson EM Marrow transplantation from related donors other than HLA-identical siblings New England Journal of Medicine 313 1985 765 771
9. Biggs JC Szer J Crilley P Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2 Blood 80 1992 1090 1093
10. Bodmer JG Marsh SG Albert ED Nomenclature for factors of the HLA system, 1995 Tissue Antigens 46 1995 1 18
11. Bortin MM Horowitz MM Rimm AA Progress report from the International Bone Marrow Transplant Registry Bone Marrow Transplantation 10 1992 113 122
12. (abstract 362) Champlin R Pasweg J Horowitz M T-cell depleted (TCD) BMT for leukemia patients with donors other than HLA-identical siblings Blood 86 10, supplement 1 1995 94a
13. chap. 1 Clift RA Marrow transplantation for chronic myeloid leukemia Buckner CD Clift RA Technical and Biological Components of Marrow Transplantation 1995 Kluwer Boston, MA 1 42
14. (review) Clift RA Appelbaum FR Thomas ED Treatment of chronic myeloid leukemia by marrow transplantation Blood 82 1993 1954 1956
15. Clift RA Buckner CD Thomas ED Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 84 1994 2036 2043
16. Clift RA Buckner CD Thomas ED Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia Blood 84 1994 4368 4373
17. (abstract) Clift RA Buckner CD Appelbaum FR The influence of patient age on the outcome of transplantation during chronic phase (CP) of chronic myeloid leukemia (CML) Blood 86 10, supplement 1 1995 617
18. Copelan EA Kapoor N Berliner M Tutschka PJ Bone marrow transplantation without total-body irradiation in patients aged 40 and older Transplantation 48 1989 65 68
19. Cullis JO Jiang YZ Schwarer AP Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation Blood 79 1992 1379 1381
20. Cullis JO Schwarer AP Hughes TP Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted marrow: feasibility of using busulphan alone for re-conditioning British Journal of Haematology 80 1992 33 39
21. Davies SM Shu XO Blazar BR Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome Blood 86 1995 1636 1642
22. Devergie A Reiffers J Vernant JP Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse Bone Marrow Transplantation 5 1990 379 386
23. Devergie A Blaise D Attal M Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM) Blood 85 1995 2263 2268
24. Drobyski WR Ash RC Casper JT Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood 83 1994 1980 1987
25. Fefer A Cheever MA Greenberg PD Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins New England Journal of Medicine 306 1982 63 68
26. Goldman JM Gale RP Horowitz MM Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion Annals of Internal Medicine 108 1988 806 814
27. Goldman JM Szydlo R Horowitz MM Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase Blood 82 1993 2235 2238
28. Goodrich JM Mori M Gleaves CA Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation New England Journal of Medicine 325 1991 1601 1607
29. Gratwohl A Gluckman E Goldman J Zwaan F Effect of splenectomy before bone marrow transplantation on survival in chronic granulocytic leukaemia Lancet ii 1985 1290 1291
30. Gratwohl A Hermans J Biezen AV No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study Bone Marrow Transplantation 10 1992 147 152
31. Gratwohl A Hermans J Niederwieser D Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation Bone Marrow Transplantation 12 1993 509 516
32. (chap. 479) Hansen JA Gooley T Clift R Unrelated donor marrow transplants for patients with chronic myeloid leukemia Blood 86 10, supplement 1 1995 123a
33. Helenglass G Treleaven J Parikh P Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia Bone Marrow Transplantation 5 1990 247 251
34. Hessner MJ Endean DJ Casper JT Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia Blood 86 1995 3987 3996
35. Higano CS Raskind W Singer JW Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation Blood 80 1992 1437 1442
36. (abstract 661) Higano C Raskind W Flowers M Alpha interferon (IFN) results in high complete cytogenetic response rate in patients with cytogenetic-only relapse of chronic myelogeneous leukemia (CML) after marrow transplantation (BMT) Blood 82 10, supplement 1 1993 669a
37. Kantarjian HM Talpaz M Definition of the accelerated phase of chronic myelogenous leukemia Journal of Clinical Oncology 6 1988 180 181
38. Klingemann H-G Storb R Fefer A Bone marrow transplantation in patients aged 45 years and older Blood 67 1986 770 776
39. Kolb HJ Mittermüller J Clemm C Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462 2465
40. (abstract 1923) Lee SJ Kuntz KM Horowitz MM A decision analysis of unrelated donor transplantation (URD BMT) for CML Blood 88 10, supplement 1 1996 484a
41. Leelasiri A Greer JP Stein RS Graft-versus-host disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone Bone Marrow Transplantation 15 1995 401 405
42. Martin PJ Clift RA Fisher LD HLA-identical marrow transplantation during accelerated phase chronic myelogenous leukemia: analysis of survival and remission duration Blood 72 1988 1978 1984
43. McGlave P Weisdorf D Evaluation of potentially curative therapy for CML Journal of Clinical Oncology 6 1988 181 182
44. McGlave P Bartsch G Anasetti C Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program Blood 81 1993 543 550
45. (abstract 1922) McGlave P Kollman C Shu XO Clinical transplantation—allogeneic mismatched or unrelated donor transplants. The first 1000 unrelated donor transplants for CML: lessons from the national marrow donor program (NMDP) experience Blood 88 10, supplement 1 1996 483a
46. Miller BA Ries LAG Hankey BF SEER Cancer Statistics Review: 1973–1990 1993 NCI Bethesda, MD
47. Nash RA Pepe MS Storb R Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate Blood 680 1992 1838 1845
48. Nash RA Pineiro LA Storb R FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors Blood 88 1996 3634 3641
49. Petersdorf EW Smith AG Mickelson EM The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation Blood 81 1993 1923 1932
50. Petersdorf EW Longton GM Anasetti C The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 86 1995 1606 1613
51. (abstract 1062) Petersdorf EW Hurley C Dupont B Analysis of 328 marrow transplants for the treatment of chronic myeloid leukemia from unrelated donors facilitated by the US national marrow donor program (NMDP): effect of HLA-DRB-1 allele disparity on clinical outcome Blood 88 10, supplement 1 1996 268a
52. Petersdorf EW Longton GM Anasetti C Definition of HLA-DQ as a transplantation antigen Proceedings of the National Academy of Sciences of the USA 93 1996 15358 15363
53. Petersdorf EW Longton GM Anasetti C Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors Blood 89 1997 1818 1823
54. Porter DL Roth MS McGarigle C Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia New England Journal of Medicine 330 1994 100 106
55. Radich JP Gehly G Gooley T Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients Blood 85 1995 2632 2638
56. Ringden O Nilsson B Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy Transplantation 40 1985 39 44
57. (abstract 1925) Servida P Gooley T Hansen JA Improved survival of haploidentical related donor marrow transplants mismatched for HLA-A or B versus HLA-DR Blood 88 10, supplement 1 1996 484a
58. Slattery JT Clift RA Buckner CD Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation Blood 89 1997 3055 3060
59. Slavin MA Osborne B Adams R Efficacy and safety of fluconazole for fungal infections after marrow transplant—a prospective, randomized, double-blind study Journal of Infectious Diseases 171 1995 1545 1552
60. Snyder DS Negrin RS O'Donnell MR Fractionated total body irradiation and high dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia Blood 84 1994 1672 1679
61. Speck B Bortin MM Champlin R Allogeneic bone marrow transplantation for chronic myelogenous leukemia Lancet 1 1984 665 668
62. Storb R Deeg HJ Whitehead J Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia New England Journal of Medicine 314 1986 729 735
63. Thomas ED Clift RA Indications for marrow transplantation in chronic myelogenous leukemia Blood 73 1989 861 864
64. Thomas ED Clift RA Fefer A Marrow transplantation for the treatment of chronic myelogenous leukemia Annals of Internal Medicine 104 1986 155 163
65. Tutschka PJ Copelan EA Kapoor N Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation Transplantation Proceedings 21 1989 2952 2954
66. Zuo L Keever CA Roth MS Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood 82 1993 2310 2318